HANDA PHARMACEUTICALS, INC.
漢達生技醫藥股份有限公司
Leave your email for change alerts (optional)
2014Founded
NT$1.7BPaid-in capital
0Plants
8Patents
NT$0.5–1BRevenue band
- Unified Business No.
- 24546157
- Industry
- Tobacco Manufacturing (1,186)
- Listing
- Listed (TPEx) (890) 6620
- Founded
- 2014-05-08
- Paid-in capital
- NT$ 1,699,819,000
- Phone
- 065057508
- Website
- https://handapharma.com.tw/zh/
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$0.5–1B
- Ownership
- Group subsidiary / corporate-held · SCINOPHARM TAIWAN LTD.、Taiwan Shen Lung Co., Ltd.
- Representative tenure
- In office since 2019-07 (7 yrs); last handover 2019-07
- Growth & profitability
- Revenue 2026-09 YoY -20.1%, year-to-date -55.9%
Gross margin 80.5%, operating margin 25.4%, net margin 25.6% (2026-Q2 YTD)
Processes & materials 1
- Biotechnology (664) · Company nameSelf-reported
Patents 8
- 2026 Cabozantinib lauryl sulfate and oral dosage form thereof
- 2025 Use of cabozantinib lauryl sulfate in preparing dosage form for treating thyroid cancer, renal cell carcinoma or hepatocellular carcinoma
- 2024 Use of nilotinib dodecyl sulfate in preparing a dosage form for treating chronic myeloid leukemia
Similar companies 10
- GREAT NOVEL THERAPEUTICS BIOTECH & MEDICALS CORPORATION Emerging stock (TPEx) < NT$20M
Shared: Biotechnology, General R&D services, Western pharmaceutical wholesale - Intelligene INC. Emerging stock (TPEx) NT$100–500M estimated
Shared: Biotechnology, Natural & engineering science R&D services - LIN BIOSCIENCE, INC. Emerging stock (TPEx) < NT$20M estimated
Shared: Natural & engineering science R&D services, Western pharmaceutical wholesale - BRIM BIOTECHNOLOGY INC. Listed (TWSE) < NT$20M
Shared: Natural & engineering science R&D services, Western pharmaceutical wholesale - INNOPHARMAX INC. Emerging stock (TPEx) NT$20–100M
Shared: Biotechnology, General R&D services, Western pharmaceutical wholesale - LUMOSA THERAPEUTICS CO., LTD. Listed (TPEx) NT$20–100M
Shared: Biotechnology, Western pharmaceutical wholesale - TRIPARTITE THERAPEUTICS INC. Emerging stock (TPEx) NT$0.5–1B estimated
Shared: Natural & engineering science R&D services - DIAMOND BIOFUND INC. Listed (TWSE) NT$1–5B
Shared: Biotechnology, Natural & engineering science R&D services - TWI BIOTECHNOLOGY, INC. Emerging stock (TPEx) NT$100–500M estimated
Shared: General R&D services - TAIWANJ PHARMACEUTICALS, CO., LTD. Emerging stock (TPEx) NT$20–100M estimated
Shared: Natural & engineering science R&D services, Western pharmaceutical wholesale